| Management of suprachoroidal hemorrhages | Şengül ÖZDEK | 233–237 |
| Anatomical and visual outcome of pars plana vitrectomy, internal limiting membrane peeling and Face-down position for one day in Idiopathic macular holes | Tunç OVALI,Özdoğan Sezin ERKUL,Çolpan OVALI,Oygar Deniz BAYLANÇİÇEK,Faruk EROĞLU,Koray AKARÇAY,Barış YENİAD | 238–244 |
| Results of comparison in use to alternative therapy methods for subfoveal choroidal neovascularization secondary to age-related macular degeneration | Osman ERDOKUR,Mehmet TETİKOĞLU,Muzaffer ÖZTÜRK,Mustafa ELÇİOĞLU | 245–250 |
| Yaşa bağlı makula dejenereransı ve santral kornea kalınlığı arasındaki ilişki | Nigar HÜSE,Şengül ÖZDEK,Alper ERDİNÇ,Berati HASANREİSOĞLU | 251–254 |
| Prognostic factors for final visual acuity and recurrence in active ocular toxoplasmosis | MELİKE BALIKOĞLU YILMAZ,MÜGE PINAR ÇAKAR ÖZDAL,Pınar ÖZDEMİR,Sevim KAVUNCU,Faruk ÖZTÜRK | 255–262 |
| Comparison of optical coherence tomography findings of primary and secondary epiretinal membranes | Çiğdem ALTAN,Hülya GÜNGEL,Pınarcı Eylem YAMAN | 263–268 |
| Ocular and systemic complications associated with intravitreal bvevacizumab injection | Gaye DEMİRÇELİK,Mehmet ÖNEN,Zeliha YAZAR,Özlem EVREN,Nil İrem UÇGUN | 269–272 |
| Comparison of panretinal photocoagulation (PRP) with PRP Plus intravitreal bevacizumab in the treatment of proliferative diabetic retinopathy | Ergür ÖZKAN,HASAN ALİ BAYHAN,Piraye KÜRKÇÜOĞLU,Tamer Takmaz,Canan GÜRDAL,İzzet CAN | 273–277 |
| Immunosuppression therapy in multifocal choroiditis and panuveitis | Gülten SUNGUR,Dicle HAZIROLAN,Remzi KASIM,Sunay DUMAN | 278–281 |
| Bietti kristallin distrofisinde santral makula fonksiyonunun değerlendirilmesi | Umut Aslı DİNÇ,Sinan TATLIPINAR,Sağdıç Ilgaz YALVAÇ,Ebru GÖRGÜN,Melda YENEREL | 282–284 |
| Pigmente paravenöz koryoretinal atrofinin fundus otofloresans bulguları | Canan Aalı UTİNE,Sinan TATLIPINAR,Ebru GÖRGÜN,Umut Aslı DİNÇ,Melda YENEREL,ALİ AYATA,Levent Murat ALİMGİL | 285–287 |